Search - tctmd.com

Displaying 161 - 180 of 892

Sort: Relevancy | Date

Aspirin as Secondary Prevention Still Subpar, Especially in Lower-Income Countries

News Daily News

Aspirin as Secondary Prevention Still Subpar, Especially in Lower-Income Countries

August 24, 2023

Chest Pain, High Troponin, and Clear Coronaries: Is CMR Needed?

News Conference News SCCT 2023

Chest Pain, High Troponin, and Clear Coronaries: Is CMR Needed?

August 08, 2023

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

News Daily News

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

August 08, 2023

SI! School Program: No Improvements in Adolescent CV Health

News Daily News

SI! School Program: No Improvements in Adolescent CV Health

August 07, 2023

High-Sensitivity Troponin Assays May Stratify Risk in Chronic CAD

News Daily News

High-Sensitivity Troponin Assays May Stratify Risk in Chronic CAD

August 01, 2023

With Focus on Stroke, Low-Dose Aspirin Still No Good for Primary Prevention

News Daily News

With Focus on Stroke, Low-Dose Aspirin Still No Good for Primary Prevention

July 26, 2023

Pitavastatin Cuts MACE in HIV-Infected Patients REPRIEVE

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

News Conference News ADA 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

June 28, 2023

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

News Conference News ADA 2023

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Michael O'Riordan

June 28, 2023

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

News Daily News

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Michael O'Riordan

June 22, 2023

FDA Approves Colchicine for Decreasing CV Events

News Daily News

FDA Approves Colchicine for Decreasing CV Events

June 20, 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

News Conference News ESOC 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

May 26, 2023

ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy

News Conference News ESOC 2023

ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy

May 25, 2023

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

May 12, 2023

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

News Daily News

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

May 05, 2023

May 2023 News Roundup

News Opinion CV Team Dispatch

May 2023 News Roundup

May 01, 2023

Inactivity Pandemic Poised to Undo CVD Prevention Advances

News Daily News

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Michael O'Riordan

April 11, 2023

MI Risk in Subclinical CAD? Both Extent and Stenosis Severity Matter

News Daily News

MI Risk in Subclinical CAD? Both Extent and Stenosis Severity Matter

Yael L. Maxwell

March 27, 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

News Conference News THT 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

March 22, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.